SCHEMBL29941012

SCHEMBL29941012

Nc1cccc(-c2cnc3cccnn23)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 5/20 0.62
DYRK3 O43781 3/20 0.62
CCNT1 O60563 3/20 0.62
CCNA2 P20248 3/20 0.62
CDK2 P24941 3/20 0.62
CDK9 P50750 3/20 0.62
CDK5 Q00535 3/20 0.62
CDK5R1 Q15078 3/20 0.62
DYRK2 Q92630 3/20 0.62
DYRK1B Q9Y463 3/20 0.62
MKNK1 Q9BUB5 2/20 0.60
FYN P06241 8/20 0.52
PRMT5 O14744 1/20 0.48
WDR77 Q9BQA1 1/20 0.48
KLK7 P49862 1/20 0.48
MEN1 O00255 1/20 0.46
PSIP1 O75475 1/20 0.46
AXL P30530 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
MAP4K4 O95819 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16331301 0.82 MKNK1 (0.60) DYRK1ADYRK3CCNT1CCNA2CDK2
SCHEMBL4052810 0.82 DYRK1A (0.65) DYRK1ADYRK3CCNT1CCNA2CDK2
SCHEMBL22189861 0.80 MKNK1 (0.77) DYRK1ADYRK3CCNA2CDK2CDK5
SCHEMBL6071200 0.80 DYRK1A (0.49) DYRK1ADYRK3CCNT1CCNA2CDK2
SCHEMBL16332085 0.79 EGLN2 (0.66) DYRK1AMKNK1KLK7
SCHEMBL10145505 0.79 DYRK1A (0.63) DYRK1ADYRK3CCNT1CCNA2CDK2
SCHEMBL29555808 0.78 DYRK1A (0.67) DYRK1ADYRK3CCNT1CCNA2CDK2
SCHEMBL5946455 0.78 DYRK3 (0.47) DYRK1ADYRK3CCNT1CCNA2CDK2
SCHEMBL13234217 0.77 DYRK1A (1.00) DYRK1ADYRK3CCNT1CCNA2CDK2
SCHEMBL2943851 0.77 DYRK1A (0.59) DYRK1ADYRK3CCNT1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed